These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6172156)

  • 1. The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini.
    Pan GZ; Martinez J; Bodanszky M; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1981 Dec; 678(3):352-7. PubMed ID: 6172156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini.
    Adachi H; Rajh HM; Tesser GI; de Pont JJ; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1981 Dec; 678(3):358-63. PubMed ID: 6172157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion.
    Villanueva ML; Martinez J; Bodanszky M; Collins SM; Jensen RT; Gardner JD
    Am J Physiol; 1982 Sep; 243(3):G214-7. PubMed ID: 6180646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists.
    Jensen RT; Jones SW; Gardner JD
    Biochim Biophys Acta; 1983 May; 757(2):250-8. PubMed ID: 6189522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Jensen RT
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini.
    Gardner JD; Walker MD; Martinez J; Priestly GP; Natarajan S; Bodanszky M
    Biochim Biophys Acta; 1980 Jul; 630(3):323-9. PubMed ID: 6156709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists.
    Jensen RT; Jones SW; Gardner JD
    Biochim Biophys Acta; 1983 Dec; 761(3):269-77. PubMed ID: 6317050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proglumide analogues: potent cholecystokinin receptor antagonists.
    Jensen RT; Murphy RB; Trampota M; Schneider LH; Jones SW; Howard JM; Gardner JD
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G214-20. PubMed ID: 2411147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbobenzoxy amino acids: structural requirements for cholecystokinin receptor antagonist activity.
    Maton PN; Sutliff VE; Jensen RT; Gardner JD
    Am J Physiol; 1985 Apr; 248(4 Pt 1):G479-84. PubMed ID: 2580448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists.
    Spanarkel M; Martinez J; Briet C; Jensen RT; Gardner JD
    J Biol Chem; 1983 Jun; 258(11):6746-9. PubMed ID: 6304053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF; Jensen RT; Lemp GF; Gardner JD
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analogue of substance P with broad receptor antagonist activity.
    Zhang L; Mantey S; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1988 Oct; 972(1):37-44. PubMed ID: 2460143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for action of cholecystokinin on enzyme secretion from pancreatic acini.
    Villanueva ML; Collins SM; Jensen RT; Gardner JD
    Am J Physiol; 1982 Apr; 242(4):G416-22. PubMed ID: 6175230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
    Vinayek R; Jensen RT; Gardner JD
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G178-81. PubMed ID: 2435164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of 2-phenylethyl ester analogues of C-terminal heptapeptide of cholecystokinin modified in Trp 30 region.
    Rolland M; Rodriguez M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1991 Aug; 38(2):181-92. PubMed ID: 1723720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
    Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the Asp-32 residue of cholecystokinin in gastric acid secretion and gastrin receptor recognition.
    Magous R; Martinez J; Lignon MF; Bali JP
    Regul Pept; 1983 Mar; 5(4):327-32. PubMed ID: 6304819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.